[148 Pages Report] The lithotripsy devices market is expected to reach USD 1.76 Billion by 2023 from USD 1.35 Billion in 2017, at a CAGR of 4.5%. The base year for this study is 2017 and the forecast period is 2018�2023.

The objectives of this study are as follows:

To define, describe, and forecast the lithotripsy devices market by type, application, end user, and region

To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)

To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market

To analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies

To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of lithotripsy devices industry and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by type, application, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources such as World Health Organization, National Institutes of Health, Canadian Urological Association, American Urology Association, Association of Clinical Urologists, European Association of Urology, British Association of Urological Surgeons, Centers for Disease Control and Prevention (CDC), World Bank, and Centers for Disease Control and Prevention (CDC) have been used to identify and collect information useful for this extensive commercial study of the market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

The key players in the market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany).

Target Audience for this Report:

Manufacturers and vendors of lithotripsy devices

Research associations related to surgeries

Various research and consulting firms

Distributors of lithotripsy devices

Government bodies

Venture capitalists

Scope of the Report:

This report categorizes the market into the following segments and subsegments:

By Type Extracorporeal Shock Wave Lithotripsy Devices Intracorporeal Lithotripsy Devices Laser Lithotripsy Devices Electrohydraulic Lithotripsy Devices Ultrasonic Lithotripsy Devices Mechanical Lithotripsy Devices

By Application Kidney Stones Ureteral Stones Pancreatic Stones Bile Duct Stones

By End User Hospitals Ambulatory Surgical Centers Other End Users

By Region North America US Canada Europe Germany UK France Rest of Europe Asia Japan China India Rest of Asia Rest of the World



Customization Options:

Company Information: Detailed company profiles of five or more market players

Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

The global lithotripsy devices market is expected to reach USD 1.76 Billion by 2023 from USD 1.41 Billion in 2018, at a CAGR of 4.5%. Growth in this market is propelled by the increasing incidence of urolithiasis and technological advancements in lithotripsy devices.

The global market is segmented on the basis of type, application, end user, and regions. By type, the market is segmented into extracorporeal shock wave lithotripsy (ESWL) devices and intracorporeal lithotripsy devices. The ESWL devices segment accounted for the largest share of the global market in 2017. ESWL is the least invasive of all stone treatments and is considered the treatment modality of choice for a majority of urinary stones. This advantage is supporting the growth of the ESWL devices market.

On the basis of application, the market is segmented into kidney stones, ureteral stones, pancreatic stones, and bile duct stones. In 2017, the kidney stones segment accounted for the largest share of the market. The large share of this segment can primarily be attributed to the increasing incidence of kidney stones.

On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and other end users. In 2017, the hospitals segment accounted for the largest share of the market. Hospitals are the largest end users of lithotripsy devices as a majority of surgical procedures are performed in hospitals.

On the basis of region, the lithotripsy devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2017, North America commanded the largest share of the market. The large share of this market segment can be attributed to the high prevalence of kidney stones in this region and the large number of surgeries performed each year.

Some of the major players operating in this market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst